Upgrade to SI Premium - Free Trial

Endo's (ENDP) Weak Results/Guidance Weigh on Specialty pharma (VRX) (HZNP) (MNK)

May 6, 2016 9:57 AM
Endo Intl's (NASDAQ: ENDP) horrendous guidance is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Short Sales Trader Talk

Next Articles